Real-world effectiveness and safety of risankizumab in patients with plaque psoriasis in whom guselkumab failed recently: A multicenter retrospective study of switching within the interleukin-23 inhibitor class - Ahmed Bagit, BSc; Khalad Maliyar, MD; Jorge R. Georgakopoulos, MD; Brian Rankin, BSc; Alexander Rimke, MSc; Asfandyar Mufti, MD; Heather Le, CRC; Ronald Vender, MD; Vimal H. Prajapati, MD; Jensen Yeung, MD (Elsevier, 2023)